LFCR (Lifecore Biomedical) Asset Turnover: 0.10 (As of Mar. 2026)

Lifecore Biomedical  (NAS:LFCR) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Lifecore Biomedical's annulized ROE % for the quarter that ended in Mar. 2026 is

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

^** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Lifecore Biomedical's annulized ROA % for the quarter that ended in Mar. 2026 is

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

Lifecore Biomedical Asset Turnover Related Terms

The historical data trend for Lifecore Biomedical's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical Asset Turnover Chart

Lifecore Biomedical Annual Data
	Trend	May16	May17	May18	May19	May20	May21	May22	May23	May24	May25
Asset Turnover		Get a 7-Day Free Trial					0.19	0.29	0.39	0.51	0.52

Lifecore Biomedical Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Sep25	Dec25	Mar26
Asset Turnover	Get a 7-Day Free Trial															0.14	0.15	0.13	0.00	0.10

LFCR vs ANIK, DERM, ASRT: Asset Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifecore Biomedical Asset Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Asset Turnover falls into.

Lifecore Biomedical Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Lifecore Biomedical's Asset Turnover for the fiscal year that ended in May. 2025 is calculated as

Lifecore Biomedical's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Lifecore Biomedical Business Description